| Literature DB >> 34065921 |
Alberto Mannu1, Marco Blangetti1, Salvatore Baldino1, Cristina Prandi1.
Abstract
Deep Eutectic Systems (DESs) are obtained by combining Hydrogen Bond Acceptors (HBAs) and Hydrogen Bond Donors (HBDs) in specific molar ratios. Since their first appearance in the literature in 2003, they have shown a wide range of applications, ranging from the selective extraction of biomass or metals to medicine, as well as from pollution control systems to catalytic active solvents and co-solvents. The very peculiar physical properties of DESs, such as the elevated density and viscosity, reduced conductivity, improved solvent ability and a peculiar optical behavior, can be exploited for engineering modular systems which cannot be obtained with other non-eutectic mixtures. In the present review, selected DESs research fields, as their use in materials synthesis, as solvents for volatile organic compounds, as ingredients in pharmaceutical formulations and as active solvents and cosolvents in organic synthesis, are reported and discussed in terms of application and future perspectives.Entities:
Keywords: API formulation; deep eutectic solvents; gas sorbents; ionothermal synthesis; materials; organic synthesis
Year: 2021 PMID: 34065921 PMCID: PMC8151193 DOI: 10.3390/ma14102494
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Classification of deep eutectic solvents.
| DES Classification | General Formula | Terms |
|---|---|---|
| Type I | Cat+X− · MClx | M = Zn, Sn, Fe, Al, Ga |
| Type II | Cat+X− · MClx · yH2O | M = Cr, Co, Cu, Ni, Fe |
| Type III | Cat+X− · RZ | Z = CONH2, COOH, OH |
| Type IV | MClx · RZ | M = Al, Zn;Z = CONH2, |
| Type V | non ionic | COOH, OH |
Figure 1Selected examples of HBAs and HBDs for the formulation of DESs. Bn = benzyl, Ph = phenyl.
Band gap energies of some binary DESs.
| HBA 1 | HBD 1 | Band Gap Energy (eV) | Reference |
|---|---|---|---|
| Choline chloride (1) | Glycolic acid (1) | 4.67 | [ |
| Choline chloride (1) | Levulinic acid (1) | 5.22 | [ |
| Choline chloride (1) | Ethylene glycol (2) | 5.92 | [ |
| Choline acetate (1) | Glycolic acid (1) | 4.73 | [ |
| Choline acetate (1) | Levulinic acid (1) | 4.70 | [ |
| Choline acetate (1) | Ethylene glycol (2) | 5.30 | [ |
| Choline chloride (1) | Zinc chloride (2) | 5.78 | [ |
| Choline chloride (1) | Copper chloride (2) | 5.20 | [ |
| Choline chloride (1) | Urea (2) | 5.16 | [ |
| Choline chloride (1) | Nickel sulphate (1) | 5.18 | [ |
| Choline chloride (3) | Imidazole (7) | 4.74 | [ |
| Choline chloride (2) | D-(+)-Glucose (1) | 5.85 | [ |
| Choline chloride (1) | Glycerol (5) | 5.56 | [ |
| Triphenylmethylphosphonium bromide (1) | Ethylene glycol (5) | 5.34 | [ |
| Triphenylmethylphosphonium bromide (1) | Glycerol (5) | 5.23 | [ |
1 The molar equivalents of HBA and HBD are indicated in parenthesis.
Figure 2Variation of the band gap energy as function of the molar ratio between choline acetate and levulinic acid. Figure made from the data reported in reference [45].
Fraction of esterified ChCl in mol% after heating for 2 h at different temperatures estimated through 1H NMR spectroscopy [61].
| DES | ChCl Esterification (mol%) | ||
|---|---|---|---|
| 60 °C | 80 °C | 100 °C | |
| ChCl/lactic acid (1:2) | 2 | 4 | 7 |
| ChCl/levulinic acid (1:2) | 2 | 10 | 17 |
| ChCl/malic acid (1:2) | 2 | 3 | 6 |
| ChCl/oxalic acid (1:1) | 0 | 6 | 17 |
| ChCl/glutaric acid (1:1) | 10 | 29 | 34 |
| ChCl/malonic acid (1:1) | 3 | 8 | 17 |
Scheme 1Esterification reaction between the ChCl and the acid component in the DES (a) and parallel degradation pathway of MA in ChCl/MA (b).
Scheme 2Degradation of ChCl/Gly (1:2) under TGA conditions: decomposition products of Gly (a) and ChCl (b) (assessed by FTIR measurements).
Materials produced by ionothermal synthesis during the period 2016–2021.
| Material | DES as Structure-Directing Agent |
|---|---|
| Imide-Linked Covalent Organic Frameworks | NaCl/KCl/ZnCl2 [ |
| Layered double hydroxides | Choline chloride/urea [ |
| Fe-LEV aluminophosphate molecular sieves | Succinic acid/choline chloride/tetraethylammonium bromide [ |
| Ti3C2 MXene a | Choline chloride and oxalic acid [ |
| Triazine and heptazine polymeric carbon nitrides (PCNs) | NaCl/KCl [ |
| MCM-41-supported metal catalysts | Choline chloride/glucose [ |
| Fe3O4 magnetic nanoparticles | Choline chloride/urea [ |
| Nanostructured ceria | Choline chloride/urea [ |
| NEU20 b | Choline chloride/oxalic acid [ |
| Cu-doped Fe3O4 nanoparticles | Choline chloride/urea [ |
| gallium phosphate Ga3(PO4)4(C2N2H8)·(H2C2N2H8)2·Cl | Choline chloride/imidazolinone [ |
| NiCo2O4 Nanorods Decorated MoS2 Nanosheets | Choline chloride/urea [ |
| High-silica zeolites | Tetramethylammonium chloride/1,6-hexanediol |
a Two-dimensional (2D) transition metal car- bides/nitrides from the 60+ group of MAX phases. b Photochromic inorganic–organic complex [C10N2H10]2[C10N2H8][Ga2(C2O4)5].
Selected DESs employed as VOCs absorbents. The best adsorbing system in terms of temperature and pressure is herein reported.
| VOC | DES a | Adsorption Capacity | Reference |
|---|---|---|---|
|
| ChCl/U (1:2) | 2.8 wt% b (303 K) | [ |
| ChCl/EG (1:2) | 2.5 wt% b (333 K) | [ | |
| ChCl/GLY (1:2) | 2.1 wt% b (303 K) | [ | |
| ChCl/LA (1:2) | 2.9 wt% b (303 K) | [ | |
| TBPB/GLY (1:1) | 2.9 wt% b (303 K) | [ | |
| TBPB/LA (1:6) | 3.0 wt% b (303 K) | [ | |
| TBPB/DA (1:2) | 3.0 wt% b (303 K) | [ | |
|
| ChCl/U (1:2) | 2.9 wt% b (303 K) | [ |
| ChCl/EG (1:2) | 2.9 wt% b (303 K) | [ | |
| ChCl/GLY (1:2) | 2.9 wt% b (303 K) | [ | |
| ChCl/LA (1:2) | 2.9 wt% b (303 K) | [ | |
| TBPB/GLY (1:1) | 2.9 wt% b (303 K) | [ | |
| TBPB/LA (1:6) | 3.0 wt% b (303 K) | [ | |
| TBPB/DA (1:2) | 3.0 wt% b (303 K) | [ | |
|
| ChCl /U (1:2) | 2.0 wt% b (303 K) | [ |
| ChCl/EG (1:2) | 2.6 wt% b (333 K) | [ | |
| ChCl/GLY (1:2) | 2.1 wt% b (303 K) | [ | |
| ChCl /LA (1:2) | 2.8 wt% b (303 K) | [ | |
| TBPB/GLY (1:1) | 2.8 wt% b (333 K) | [ | |
| TBPB/LA (1:6) | 2.8 wt% b (303 K) | [ | |
| TBPB/DA (1:2) | 3.0 wt% b (303 K) | [ | |
|
| TBAB/TEA (1:5) | 2.5 wt% b (303 K) | [ |
| TEAB/TEA (1:5) | 2.9 wt% b (303 K) | [ | |
| ChCl/MDEA (1:4) | 3.0 wt% b (303 K) | [ | |
| Ch/Cl/TEA (1:5) | 3.0 wt% b (303 K) | [ | |
| ChCl/MDEA (1:5) | 4.0 wt% b (303 K) | [ | |
| ChCl/TEA (1:4) | 6.0 wt% b (303 K) | [ | |
| ChCl/DEA (1:4) | 15 wt% b (303 K) | [ | |
| TBAB/MEA (1:5) | 16 wt% b (303 K) | [ | |
| TBAC/MEA (1:5) | 17.5 wt% b (303 K) | [ | |
| TEAB/MEA (1:5) | 18 wt% b (303 K) | [ | |
| TEAC/MEA (1:5) | 22.5 wt% b (303 K) | [ | |
| ChCl/MEA (1:4) | 23 wt% b (303 K) | [ | |
| TMAC/MEA (1:5) | 23 wt% b (303 K) | [ | |
| ChCl/MEA (1:5) | 25 wt% b (303 K) | [ | |
| TEAC/MEA/TEA | 23 wt% b (303 K) | [ | |
| ChCl/MEA/TEA | 23 wt% b (303 K) | [ | |
| TEAC/MEA/MDEA | 23 wt% b (303 K) | [ | |
| ChCl/MEA/MDEA | 23 wt% b (303 K) | [ | |
| TMAC/MEA/TEA | 23 wt% b (303 K) | [ | |
| TMAC/MEA/MDEA | 30 wt% b (303 K) | [ | |
| TMAC/MEA/FeCl3 (1:5:0.1) | 25 wt% b (303 K) | [ | |
| TMAC/MEA/CuCl2 (1:5:0.1) | 26 wt% b (303 K) | [ | |
| TMAC/MEA/NiCl2 (1:5:0.1) | 26 wt% b (303 K) | [ | |
| TMAC/MEA/CoCl2 (1:5:0.1) | 26 wt% b (303 K) | [ | |
| TMAC/MEA/NH4Cl (1:5:0.1) | 28 wt% b (303 K) | [ | |
| TMAC/MEA/ZnCl2 (1:5:0.1) | 30 wt% b (303 K) | [ | |
| TMAC/MEA/LiCl (1:5:0.1) | 30 wt% b (303 K) | [ | |
| ChCl/U (1:2) | 3.559 molVOC/kgDES (303 K, 5.654 bar) | [ | |
| 1-butyl-3-methyl imidazolium methanesulfonate /U (1:1) | 0.422 molVOC/kgDES (303 K, 6.984 bar) | [ | |
|
| ChCl/PhOH/EG (1:5:4) | 9.619 molVOC/kgDES (298 K, 101 kPa) | [ |
| ChCl/PhOH/EG (1:7:4) | 7.652 molVOC/kgDES (313 K, 101 kPa) | [ | |
| ChCl/U (1:2) | 2.213 molVOC/kgDES (298 K, 95 kPa) | [ | |
| ChCl/resorcinol/GLY (1:3:5) | 9.982 molVOC/kgDES (298 K, 101 kPa) | [ | |
| ChCl/ | 6.471 molVOC/kgDES (313 K, 101 kPa) | [ | |
| NH4SCN/GLY (2:3) | 10.353 molVOC/kgDES (298 K, 101 kPa) | [ | |
|
| ChCl/guaiacol (1:3; 1:4; 1:5) | 0.528; 0.501; 0.479 gVOC for gDES | [ |
| ChCl/cardanol (1:3; 1:4; 1:5) | 0.196; 0.170; 0.149 gVOC for gDES | [ | |
| ChCl/LA (1:3) | 0.557 gVOC for gDES | [ | |
| TBAC/LA (1:3) | 0.622 gVOC for gDES | [ | |
| ChCl/EG (1:2) | 2.25 mol SO2/mol DES | [ | |
| ChCl/MA (1:1) | 1.40 mol of SO2 mol DES | [ | |
| ChCl/U (1:2) | 1.57 mol of SO2 mol DES | [ | |
| ChCl/ thiourea (1:1) | 2.37 mol of SO2 mol DES | [ | |
|
| 1-butyl-3-methyl imidazolium methanesulfonate /U (1:1) | 4.150 molVOC/kgDES (313 K, 5.258 bar) | [ |
|
| 1-butyl-3-methyl imidazolium methanesulfonate /U (1:1) | 1.034 molVOC/kgDES (303 K, 6.450 bar) | [ |
a ChCl: choline chloride, U: urea, GLY: glycerol, EG: ethylene glycol, LA: lactic acid, DA: decanoic acid, TBPB: tetrabutylphosphonium bromide, TBAB: tetrabutylammonium bromide, TEA: triethylamine, TEAB: tetraethylammonium bromide, MDEA: methyldiethanolamine, MEA: methylethanolamine, TEAC: tetraethylammonium chloride, TMAC: tetramethylammonium chloride. b Data extrapolated from the plots reported by the Authors. The numbers reported in the table are approximated.
Figure 3Pharmaceutical applications of Deep Eutectic Solvents: state-of-the-art.
Figure 4Fields of the most recent applications of DESs as solvents or co-catalysts in organic transformations.
Scheme 3First successful organic transformations featuring organometallic reagents in DESs under air.
Scheme 4Sequential DoM and quenching with electrophile for selective functionalization of 2,2-diphenylTHF.
Scheme 5One-pot DLL/ring-opening/C–C bond formation on o-tolylTHFs for the synthesis of functionalized primary alcohols.
Scheme 6Organolithium-directed chemoselectivity in ethereal ChCl/Gly (1:2): fast DoM and SNAc on sterically hindered benzamides in CPME/DES.
Scheme 7Regioselective synthesis of toluene derivatives via ultrafast DLL in ethereal ChCl/Gly (1:2).
Scheme 8Scope of the Nazarov cyclization in acidic DESs.
Scheme 9Ru-catalyzed transfer hydrogenation of carbonyl and imine compounds in TBABr/HCOOH under mild conditions.
Scheme 10Ligand-free iron salt incorporated within the DES: Meyer-Schuster rearrangement mediated by FeCl3·6H2O/Gly (3:1).